Question: Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD), it was licensed in 2000 to EyeTech Pharmaceuticals, now called what, an American pharmaceutical company based in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom?
Sentence (from "Joan Miller"): She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
Relevant evidence: No